240 related articles for article (PubMed ID: 31859762)
1. [Inappropriate antifungal prescription and the need for antifungal stewardship programs].
Osorio-Lombana JP; Cuervo-Maldonado SI; López-Mora MJ; Gómez-Rincón JC
Rev Chilena Infectol; 2019 Aug; 36(4):403-413. PubMed ID: 31859762
[TBL] [Abstract][Full Text] [Related]
2. Antifungal stewardship considerations for adults and pediatrics.
Hamdy RF; Zaoutis TE; Seo SK
Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344
[TBL] [Abstract][Full Text] [Related]
3. Antifungal stewardship in solid-organ transplantation: What is needed?
Whitney L; Armstrong-James D; Lyster HS; Reed AK; Dunning J; Nwankwo L; Cheong J
Transpl Infect Dis; 2022 Oct; 24(5):e13894. PubMed ID: 36254506
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children.
Ferreras-Antolín L; Irwin A; Atra A; Chapelle F; Drysdale SB; Emonts M; McMaster P; Paulus S; Patel S; Rompola M; Vergnano S; Whittaker E; Warris A
Pediatr Infect Dis J; 2022 Mar; 41(3):e69-e74. PubMed ID: 34784303
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of the impact of antifungal stewardship interventions in the United States.
Hart E; Nguyen M; Allen M; Clark CM; Jacobs DM
Ann Clin Microbiol Antimicrob; 2019 Aug; 18(1):24. PubMed ID: 31434563
[TBL] [Abstract][Full Text] [Related]
6. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
7. Training should be the first step toward an antifungal stewardship program.
Valerio M; Muñoz P; Rodríguez-González C; Sanjurjo M; Guinea J; Bouza E;
Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):221-7. PubMed ID: 25066382
[TBL] [Abstract][Full Text] [Related]
8. Improving quality of antifungal use through antifungal stewardship interventions.
Lachenmayr SJ; Strobach D; Berking S; Horns H; Berger K; Ostermann H
Infection; 2019 Aug; 47(4):603-610. PubMed ID: 30805898
[TBL] [Abstract][Full Text] [Related]
9. Antifungal treatment in haematological and oncological patients: Need for quality assessment in routine care.
Lachenmayr SJ; Berking S; Horns H; Strobach D; Ostermann H; Berger K
Mycoses; 2018 Jul; 61(7):464-471. PubMed ID: 29575106
[TBL] [Abstract][Full Text] [Related]
10. The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan.
Kawaguchi H; Yamada K; Imoto W; Yamairi K; Shibata W; Namikawa H; Yoshii N; Nakaie K; Okada Y; Fujita A; Shinoda Y; Nakamura Y; Kaneko Y; Nagayama K; Kakeya H
J Infect Chemother; 2019 Jun; 25(6):458-462. PubMed ID: 30803878
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
Reslan Z; Lindsay J; Kerridge I; Gellatly R
Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
[TBL] [Abstract][Full Text] [Related]
12. An Australian perspective on antimicrobial stewardship programs and transplantation.
Stewart AG; Isler B; Paterson DL
Transpl Infect Dis; 2022 Oct; 24(5):e13912. PubMed ID: 36254503
[TBL] [Abstract][Full Text] [Related]
13. Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital.
Markogiannakis A; Korantanis K; Gamaletsou MN; Samarkos M; Psichogiou M; Daikos G; Sipsas NV
Int J Antimicrob Agents; 2021 Jan; 57(1):106255. PubMed ID: 33279582
[TBL] [Abstract][Full Text] [Related]
14. Antifungal stewardship: developments in the field.
Urbancic KF; Thursky K; Kong DCM; Johnson PDR; Slavin MA
Curr Opin Infect Dis; 2018 Dec; 31(6):490-498. PubMed ID: 30299362
[TBL] [Abstract][Full Text] [Related]
15. How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: A single-centre study.
Mularoni A; Adamoli L; Polidori P; Ragonese B; Gioè SM; Pietrosi A; Tuzzolino F; Guadagnino G; Monaco F; Grossi PA; Conaldi PG; Luca A; Mikulska M
Mycoses; 2020 Jul; 63(7):746-754. PubMed ID: 32358860
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the prescription, consumption and costs of antifungal drugs in a pediatric hospital in Chile].
Barraza M; Barnafi N; Ortiz G; Torres JP; Coria P; Catalán P; Palma J; Morales J
Rev Chilena Infectol; 2018 Aug; 35(4):351-357. PubMed ID: 30534920
[TBL] [Abstract][Full Text] [Related]
17. Effect of an intervention to improve the prescription of antifungals in pediatric hematology-oncology.
Santiago-García B; Rincón-López EM; Ponce Salas B; Aguilar de la Red Y; Garrido Colino C; Martínez Fernández-Llamazares C; Saavedra-Lozano J; Hernández-Sampelayo Matos T;
Pediatr Blood Cancer; 2020 Apr; 67(4):e27963. PubMed ID: 31407514
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
Fung M; Kim J; Marty FM; Schwarzinger M; Koo S
PLoS One; 2015; 10(11):e0140930. PubMed ID: 26554923
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Use of Novel Biomarkers to Augment Antimicrobial Stewardship Program Activities.
Stover KR; Kenney RM; King ST; Gross AE
Pharmacotherapy; 2018 Feb; 38(2):271-283. PubMed ID: 29245184
[TBL] [Abstract][Full Text] [Related]
20. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.
Paige E; Haywood P; Xie M; Worth L; Thursky K; Urbancic K; Bajel A; Slavin M
Leuk Lymphoma; 2019 Oct; 60(10):2373-2383. PubMed ID: 31096813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
